epigenhub.org

CD BioSciences is a life sciences supplier focused on epigenetics research, serving researchers worldwide with products, technical services, and research solutions. Its offerings support studies of epigenetic mechanisms, biomarkers, disease, and drug development. Services cover DNA and RNA methylation and other modifications, histone and nucleosome analysis, chromatin accessibility and profiling, regulator interactions, bioinformatics, and epigenetic drug discovery. Methods include sequencing, mass spectrometry, imaging and structural approaches, binding assays, and cell-based testing.

The company’s product portfolio includes proteins and enzymes, antibodies, synthetic peptides, bioactive small molecules, cell lines, nucleosomes, extracts and lysates, research kits, and specialized instruments for chromatin and sequencing workflows. These products are intended for applications such as modification analysis, enzyme and compound screening, protein interaction studies, and chromatin research. CD BioSciences also offers experienced contract research support for epigenetic drug discovery and tailored experimental services. Its stated approach emphasizes scientifically proficient assistance, advanced technologies and instruments, product variety, and quality assurance, with the aim of helping customers conduct epigenetics research and achieve reliable experimental results.